Smoking is associated with impaired glucose regulation and a decrease in insulin sensitivity and the disposition index in first-degree relatives of type 2 diabetes subjects independently of the presence of metabolic syndrome

Acta Diabetologica

Volumn 51, Issue 5, 2014, Pages 793-799

  Piatti, PierMarco ^a   Setola, Emanuela ^a   Galluccio, Elena ^a   Costa, Sabrina ^a   Fontana, Barbara ^a   Stuccillo, Michela ^a   Crippa, Valentina ^a   Cappelletti, Alberto ^a   Margonato, Alberto ^a   Bosi, Emanuele ^a   Monti, Lucilla D ^a  

^a Faculty of Medicine   (Italy)

Author keywords

Diabetes mellitus; First degree relatives; Glucose tolerance; Impaired glucose regulation; Insulin resistance; Insulin sensitivity; Smoking

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FIRST DEGREE RELATIVE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; RISK ASSESSMENT; SEDENTARY LIFESTYLE; SEX DIFFERENCE; SMOKING; SMOKING HABIT; ADVERSE EFFECTS; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; PEDIGREE;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PEDIGREE; SMOKING;

EID: 84919475525     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-014-0599-6     Document Type: Article

References (32)

1. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J (2007) Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 298:2654–2664
2. Zhang L, Curhan GC, Hu FB, Rimm EB, Forman JP (2011) Association between passive and active smoking and incident type 2 diabetes in women. Diabetes Care 34:892–897
3. Kowall B, Rathmann W, Strassburger K, Heier M, Holle R, Thorand B, Giani G, Peters A, Meisinger C (2010) Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population: the KORA S4/F4 cohort study. Eur J Epidemiol 25:393–402
4. Nakanishi N, Takatorige T, Suzuki K (2005) Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. Ind Health 43:295–301
5. Eliasson B, Attvall S, Taskinen MR, Smith U (1994) The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb 14:1946–1950
6. Ronnemaa T, Ronnemaa EM, Puukka P, Pyorala K, Laakso M (1996) Smoking is independently associated with high plasma insulin levels in nondiabetic men. Diabetes Care 19:1229–1232
7. Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bonora E (1997) Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:3619–3624
8. Cena H, Fonte ML, Turconi G (2011) Relationship between smoking and metabolic syndrome. Nutr Rev 69:745–753
9. Corwin EJ, McCoy CS, Whetzel CA, Ceballos RM, Klein LC (2006) Risk indicators of metabolic syndrome in young adults: a preliminary investigation on the influence of tobacco smoke exposure and gender. Heart Lung 35:119–129
10. Chen CC, Li TC, Chang PC, Liu CS, Lin WY, Wu MT, Li CI, Lai MM, Lin CC (2008) Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. Metabolism 57:544–548
11. Berlin I (2008) Smoking-induced metabolic disorders: a review. Diabetes Metab 34:307–314
12. Bartler PJ (2011) The causes and consequences of low levels of high density lipoproteins in patients with diabetes. Diabetes Metab J 35:101–106
13. Rafalson L, Donahue RP, Dmochowski J, Rejman K, Dorn J, Trevisan M (2009) Cigarette smoking is associated with conversion from normoglycemia to impaired fasting glucose: the Western New York Health Study. Ann Epidemiol 19:365–371
14. Oda E (2012) Metabolic syndrome: its history, mechanisms, and limitations. Acta Diabetol 49:89–95
15. Daniele G, Guardado Mendoza R, Winnier D, Fiorentino V, Pengou Z, Cornell J, Andreozzi F, Jenkinson C, Cersosimo E, Federici M, Tripathy D, Folli F (2014) The inflammatory status score including IL6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol 51:123–131
16. Meshkani R, Zargari M, Larijani B (2011) The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects. Acta Diabetol 48:88–89
17. Fadini GP, Vigili De Kreutzenberg S, Gjini R, Avogaro A (2011) The metabolic syndrome influences the response to incretin-based therapies. Acta Diabetol 48:219–225
18. Topolski TD, LoGerfo J, Patrick DL, Williams B, Walwick J, Patrick MMB (2006) The rapid assessment of physical activity (RAPA) among older adults. Prev Chronic Dis 3:1–8
19. Monti LD, Setola E, Lucotti PCG, Marrocco-Trischitta MM, Comola M, Galluccio E, Poggi A, Mammì S, Catapano AL, Comi G, Chiesa R, Bosi E, Piatti PM (2012) Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomised, double-blind, placebo-controlled trial. Diabetes Obes Metab 14:893–900
20. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome–a new worldwide definition. IDF epidemiology task force consensus group. Lancet 366:1059–1062
21. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–2410
22. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessment of insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539–548
23. Pacini G, Mari A (2003) Methods for clinical assessment of insulin sensitivity and β-cell function. Best Pract Res Clin Endocrinol Metab 17:30–322
24. Dalfrà MG, Pacini G, Parretti E, Ragazzi E, Mello G, Lapolla A (2011) Elevated insulin sensitivity and β -cell function during pregnancy in mothers of growth-restricted newborns. Am J Physiol Metab 30:E25–E30
25. Stadler M, Tomann L, Storka A, Wolzt M, Peric S, Bieglmayer C, Pacini G, Dickson SL, Brath H, Bech P, Prager R, Korbonits M (2014) Effects of smoking cessation on b-cell function, insulin sensitivity, body weight, and appetite. Eur J Endocrinol 170:219–227
26. Stumvoll M, Van Haeften T, Fritsche A, Gerich J (2001) Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 24:796–797
27. Retnakaran R, Qi Y, Goran MI, Hamilton J (2009) Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 26:1198–1203
28. Zinman B, Harris SB, Neuman J, Gerstein HC, Retnakaran RR, Raboud J, Qi Y, Hanley AJG (2010) Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study. Lancet 376:103–111
29. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM (1992) Insulin resistance and cigarette smoking. Lancet 339:1128–1130
30. Sonmez A, Dogru T, Yilmaz MI, Tasci I, Ocal R, Ozgurtas T, Kilic S, Erbil K, Erikci S, Tsao P (2006) Adiponectin and insulin resistance in young and healthy smokers. Endocr J 53:729–734
31. Bruin JE, Petre MA, Raha S, Morrison KM, Gerstein HC, Holloway AC (2008) Fetal and neonatal nicotine exposure in Wistar rats causes progressive pancreatic mitochondrial damage and beta cell dysfunction. PLoS ONE 3:e3371
32. Mennen LI, Balkau B, Charles MA, D’Hour A, le Mauff JM (1999) Gender differences in the relation between fibrinogen, tissue-type plasminogen activator antigen and markers of insulin resistance: effects of smoking. D.E.S.I.R. Study Group. Data from an Epidemiological Study on Insulin Resistance Syndrome. Thromb Haemost 82:1011–1106